| Neurocrine Signs US$1.7 B Epilepsy Pact with Xenon |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Takeda Buys into Viral Immunology with US$1 B Turnstone Deal |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Jazz Pharmaceuticals Licenses PharmaMar’s Lung Cancer Drug Lurbinectedin |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Roche Licenses Sarepta’s DMD Therapy for US$2.88 B |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Astellas Pushes Further into Gene Therapy Field with US$3 B Audentes Buy |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Sanofi Ups Immuno-oncology Investment with US$2.5 B Synthorx Buy |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Merck Validates BTK Inhibitors with US$2.7 B ArQule Buy |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Deal Trends in Gene Therapy |
Abstract
pdf
|
|
Michelle Liu & Taskin Ahmed |
|
